Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Warner-Lambert
|
| gptkbp:acquisitionYear |
1970
|
| gptkbp:founded |
1866
|
| gptkbp:founder |
gptkb:George_S._Davis
Hervey C. Parke |
| gptkbp:headquarters_location |
gptkb:Detroit,_Michigan,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Parke, Davis & Co.
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableEmployee |
gptkb:Parke-Davis_Research_Laboratory
|
| gptkbp:notablePerson |
gptkb:Frederick_Banting
gptkb:Parke-Davis_Research_Laboratory |
| gptkbp:notableProduct |
gptkb:Chlorpromazine
Adrenalin (epinephrine) Benadryl (diphenhydramine) Dilantin (phenytoin) |
| gptkbp:Pfizer_acquisition_year |
2000
|
| gptkbp:subsequent_owner |
gptkb:Pfizer
|
| gptkbp:bfsParent |
gptkb:Jokichi_Takamine
|
| gptkbp:bfsLayer |
7
|